Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Pfizer Ltd Reports 65.7% Net Profit Increase to Rs 313 Crore in September Quarter

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Pfizer Ltd Reports 65.7% Net Profit Increase to Rs 313 Crore in September Quarter

Analysed 3 Nov 2026·2 sources analysed·New Delhi, India·Business
Pfizer Ltd Reports 65.7% Net Profit Increase to Rs 313 Crore in September QuarterPreviousNext

Pfizer Ltd reported a 65.7% rise in net profit to Rs 313.25 crore for the September quarter, driven by exceptional gains of Rs 132.06 crore from the sale of Minipress XL by its parent company. The company’s profit before tax and exceptional items increased 13.9% to Rs 290.77 crore, while total income rose to Rs 774.19 crore. Pfizer discontinued manufacturing Minipress XL from September 7, 2026. Shares closed 3.37% higher at Rs 3,760.5 on the BSE.

Sentiment
66%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (66/100). Lens Score 39/100.

Outlets measured: businessstandard, news18. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 3 Nov 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Positive (66/100)

Sentiment was consistent across outlets (65–68/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

news18 broke this story on 3 Nov, 10:17 am. Other outlets followed.

3 Nov, 10:17 am2 sources · 14 min3 Nov, 10:31 am
  1. 1
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
TRAI Announces New Telecom Interconnection Regulations Effective January 2027
Next →
Bhatia Communications Reports Strong Q2 Results and Declares Second Interim Dividend
news183 Nov, 10:17 am
Pfizer posts 65.7 pc rise in net profit to Rs 313 cr in Sept quarter
  • 2
    businessstandard3 Nov, 10:31 am
    Pfizer Q2 results: Net profit rises 65.7 to 313 cr, income at 774 cr
  • Who's involved

    Institutions and figures named across source coverage.

    Corporate
    Pfizer LimitedPfizer Incorporated United States of America

    Story context

    Category
    Business
    Location
    New Delhi, India
    Sources analysed
    2
    Last analysed
    3 Nov 2026
    Key entities
    Net incomePfizerCroreIndian rupeeFiscal yearBombay Stock ExchangeUnited StatesZydus WellnessBSE SENSEXFast-moving consumer goodsITC (company)Axis Bank